September marks PMOS Awareness Month, a dedicated period to shed light on Polyendocrine Metabolic Ovarian Syndrome (formerly and widely known as Polycystic Ovary Syndrome or PCOS). While conversations surrounding PMOS often center on hyperandrogenism, irregular cycles, and metabolic health, an equally crucial piece of the puzzle often gets overlooked: the profound role of sleep.
In their narrative review, “The role of sleep in PCOS: what we know and what to consider in the future”, authors P. Teo, B. A. Henry, L. J. Moran, S. Cowan, and C. Bennett highlight how intrinsic sleep disturbances are to the PMOS experience—and why sleep hygiene must become a cornerstone of standard care (Teo et al., 2022).
The Unseen Burden: Sleep Architecture and PMOS
The core finding of the review by Teo et al. (2022) is that individuals living with PMOS face significantly higher rates of sleep pathology compared to the general population. Sleep disturbance in PMOS is not merely a consequence of staying up late; it is a complex, bi-directional physiological challenge driven by insulin resistance, elevated androgen levels, and altered endocrine signaling (Teo et al., 2022).
The review underscores key sleep disruptions common in PMOS:
- Obstructive Sleep Apnea (OSA): Hyperandrogenism and insulin resistance elevate the risk of clinical sleep conditions like OSA in individuals with PMOS. Upper-airway collapse during sleep leads to intermittent hypoxia (oxygen deprivation), which triggers systemic inflammation and worsens underlying metabolic dysfunction (Teo et al., 2022).
- Impaired Sleep Architecture: Beyond OSA, individuals with PMOS frequently report non-clinical sleep disturbances such as difficulty falling asleep, waking after sleep onset, and diminished restorative sleep. This fragmentation compromises physical recovery and exacerbates daytime fatigue (Teo et al., 2022).
The Vicious Cycle: Sleep, Hormones, and Mental Health
Teo et al. (2022) highlight that sleep deprivation is both a symptom and a driver of PMOS severity. When sleep quality degrades, the body experiences heightened sympathetic nervous system activity and oxidative stress, which increases adipose tissue deposition and exacerbates insulin resistance.
Metabolic instability directly feeds into psychological distress. Poor sleep dampens overall daily functioning and resilience, compounding the mental health challenges frequently documented in PMOS patients. Furthermore, sleep disruption can undermine positive lifestyle changes made after diagnosis, making long-term management even more difficult (Teo et al., 2022).
Future Directions: Making Sleep a Clinical Priority
A key takeaway from Teo and colleagues (2022) is the urgent need to integrate sleep assessment into routine clinical care for PMOS. The authors advocate for:
- Screening and Diagnostic Focus: Utilizing polysomnography (PSG) and diagnostic screening tools to detect hidden OSA and sleep disorders early (Teo et al., 2022).
- Targeted Interventions: Exploring interventions like Cognitive Behavioral Therapy (CBT) for sleep management—which has proven effective in the general population—to help patients with PMOS sustain positive health behaviors (Teo et al., 2022).
- Lifestyle Integration: Supporting sleep optimization alongside traditional diet and physical activity strategies to improve overall cardiometabolic and psychological outcomes (Teo et al., 2022)
A Call to Action for PMOS Awareness Month
As we observe PMOS Awareness Month this September, it is essential to reframe how we approach this multifaceted condition. Managing PMOS is not solely about treating outward symptoms; it requires nurturing the foundational pillars of health. Restful, restorative sleep is non-negotiable for metabolic balance, hormonal harmony, and mental resilience. Addressing sleep hygiene today provides a powerful, evidence-based strategy to regain control over both body and mind.
References
Teo, P., Henry, B. A., Moran, L. J., Cowan, S., & Bennett, C. (2022). The role of sleep in PCOS: what we know and what to consider in the future. Expert Review of Endocrinology & Metabolism, 17(4), 305–318. https://doi.org/10.1080/17446651.2022.2082941